« Back
Home /
Lasofoxifene (tartrate)

Lasofoxifene (tartrate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	50 mg
Item no.	HY-A0038-50mg
Targets	Estrogen Receptor/ERR
CASRN	190791-29-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Lasofoxifene (CP-336156) tartrate is an orally active and selective estrogen receptor modulator (SERM)[1]. Lasofoxifene tartrate exhibits an anti-osteoporotic function and also inhibits primary tumor growth and metastases. Lasofoxifene tartrate can be used for the research of breast cancer and postmenopausal osteoporosis[1][2].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
MolecularWeight	563.64
Clinical_Information	Launched
Manufacturers Research_Area	Endocrinology; Cancer
Solubility	DMSO : 83.33 mg/mL (ultrasonic)
Manufacturers Target	Estrogen Receptor/ERR
Pathway	Vitamin D Related/Nuclear Receptor
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-A0038-50mg-safety-datasheet.pdf